Market Research Logo

Estonia Pharmaceuticals and Healthcare Report Q2 2015

Estonia Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Positive consumer dynamics will drive growth in pharmaceutical sales in Estonia. We see an opportunity emerging as the Baltic countries of Lithuania, Latvia and Estonia jointly procure pharmaceuticals for their collective needs. Despite the small size of Estonia's pharmaceuticals industry, there is the potential for manufacturers to use the country as a low-cost export base, rather than focusing on the country's own market. The key risk continues to be tense Western-Russian relations.

Headline Expenditure Projections

Pharmaceutical sales will rise from EUR289mn (USD388mn) in 2014 to EUR307mn (USD338mn) in 2015, up 6.2% in local currency terms and down 12.8% in US dollar terms.

Healthcare spending will rise from EUR1.12bn (USD1.51bn) in 2014 to EUR1.19bn (USD1.31bn) in 2015, up 6.2% in local currency terms and down 12.8% in US dollar terms.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Estonia 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2011-2019)
Prescription Drug Market Forecast
Table: Leading Anatomical Therapeutic Chemical (ATC) Groups By Pharmaceutical Sales, 2004-2010 (%)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Estonia 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Estonia 2013-2019, USD)
Table: Pharmaceutical Trade Data And Forecasts (Estonia 2013-2019, EUR)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: Economic Activity (Estonia 2010-2019)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Estonia Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Table: Leading Causes Of Death, 2005-2010
Healthcare Sector
Healthcare Reform
Healthcare Provision
Table: Healthcare Resources, Healthcare Activity And Healthcare Personnel, 2009-2014
Healthcare Funding
Table: HIF Healthcare Expenditure, 2006-2011 (EURmn)
Healthcare Insurance
Table: Reimbursement Spending By Key Therapeutic Area, 2010-2011 (EURmn)
Table: Medicinal Products Reimbursed For Insured Patients, 2009-2011 (EURmn)
Healthcare Tourism
Research And Development
Table: Members Of EBio, 2011
Clinical Trials
Table: Number Of Clinical Trials, 1991-2011
Regulatory Development
Table: Key Health Insurance Indicators, 2007-2011
Table: Expenditure By Reimbursed Prescription Medicinal Products, 2005-2010 (EEK '000)
Competitive Landscape
Table: Members Of The Association Of International Pharmaceutical Manufacturers In Estonia (APME)
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: Pharmacies And Pharmacy Market Ratios, 2004-2009
Company Profile
GlaxoSmithKline
Pfizer
Novartis
Sanofi
Merck & Co
Grindeks (incorporating Tallinn Pharmaceutical Plant)
Demographic Forecast
Table: Population Headline Indicators (Estonia 1990-2025)
Table: Key Population Ratios (Estonia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Estonia 1990-2025)
Table: Population By Age Group (Estonia 1990-2025)
Table: Population By Age Group % (Estonia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report